Managing patients with non-Hodgkin lymphoma

How to best manage first relapse in DLBCL outside of CAR-TПодробнее

How to best manage first relapse in DLBCL outside of CAR-T

Managing Toxicities and Access in Follicular Lymphoma CareПодробнее

Managing Toxicities and Access in Follicular Lymphoma Care

Managing Follicular Lymphoma: The Role of Observation and Watchful WaitingПодробнее

Managing Follicular Lymphoma: The Role of Observation and Watchful Waiting

Follicular Lymphoma Expert Q&A: Coping with Relapse and Managing Treatment Side EffectsПодробнее

Follicular Lymphoma Expert Q&A: Coping with Relapse and Managing Treatment Side Effects

Management of Older Adults with Hodgkin Lymphoma with Dr. Andrew EvensПодробнее

Management of Older Adults with Hodgkin Lymphoma with Dr. Andrew Evens

Lymphoma Management Updates -A. W. Beaven - 20241023Подробнее

Lymphoma Management Updates -A. W. Beaven - 20241023

Paediatric Hematology Oncology Series : Non Hodgkin LymphomaПодробнее

Paediatric Hematology Oncology Series : Non Hodgkin Lymphoma

Classification and Management of Hodgkin LymphomaПодробнее

Classification and Management of Hodgkin Lymphoma

Non Hodgkin Lymphoma EvidenceПодробнее

Non Hodgkin Lymphoma Evidence

Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered CareПодробнее

Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care

Update on Hodgkin Lymphoma Webinar | Lymphoma Research Foundation WebinarsПодробнее

Update on Hodgkin Lymphoma Webinar | Lymphoma Research Foundation Webinars

Update on Follicular Lymphoma | Lymphoma Research Foundation WebinarsПодробнее

Update on Follicular Lymphoma | Lymphoma Research Foundation Webinars

Administering Outpatient CAR T-cell Therapy in Non-Hodgkin Lymphoma | Radhika Bansal, MD | EHA 2024Подробнее

Administering Outpatient CAR T-cell Therapy in Non-Hodgkin Lymphoma | Radhika Bansal, MD | EHA 2024

How Hodgkin Lymphoma Treatment is CHANGING: Less Chemo, Targeted Drugs & Longer SurvivalПодробнее

How Hodgkin Lymphoma Treatment is CHANGING: Less Chemo, Targeted Drugs & Longer Survival

Non-Hodgkin Lymphoma | Martin Hutchings, MD, PhDПодробнее

Non-Hodgkin Lymphoma | Martin Hutchings, MD, PhD

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew MatasarПодробнее

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Non-Hodgkin lymphoma: diagnosis, prevention and risk factorsПодробнее

Non-Hodgkin lymphoma: diagnosis, prevention and risk factors

00 Lymphoma Management 2023 Week 1 High grade non Hodgkin lymphomaПодробнее

00 Lymphoma Management 2023 Week 1 High grade non Hodgkin lymphoma

02 Lymphoma Management 2023 Week 3 High grade non Hodgkin lymphoma other entitiesПодробнее

02 Lymphoma Management 2023 Week 3 High grade non Hodgkin lymphoma other entities

Progress in understanding and treating non-Hodgkin lymphoma (NHL)Подробнее

Progress in understanding and treating non-Hodgkin lymphoma (NHL)

Новости